NP2 Enkephalin For Treatment of Intractable Cancer Pain
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darren Wolfe, Ph.D.
Diamyd Inc
Study Director - David Fink, M.D.
University of Michigan
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hope Research Institute
Phoenix, Arizona, United States
- Arizona Clinical Research Center
Tucson, Arizona, United States
- Compassionate Cancer Care Medical Group, Inc.
Corona, California, United States
- Cancer Care Associates
Fresno, California, United States
- Triwest Research Associates
La Mesa, California, United States
- White Memorial Medical Center
Los Angeles, California, United States
- Hematology Oncology Associates
Oakland, California, United States
- Advanced Pharma Cr
Miami, Florida, United States
- Better Health Clinical Research Inc
Newnan, Georgia, United States
- Christie Clinic
Champaign, Illinois, United States
- Global Scientific Innovations
Evansville, Indiana, United States
- Montana Cancer Institute Foundation
Missoula, Montana, United States
- Center for Clinical Research
Winston-Salem, North Carolina, United States
- Signal Point Clinical Research Center
Middletown, Ohio, United States
- Pain Research of Oregon
Eugene, Oregon, United States
- Hematology Oncology Associatesof Rhode Island
Cranston, Rhode Island, United States
- Medical Therapy and Research
San Antonio, Texas, United States
- Medical Oncology Associates
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2011
- Primary completion
- 31 Jul 2012
- Completion
- 30 Nov 2013
- Last update posted
- 8 Aug 2014
- Registered enrollment
- 33
- Registry id
- NCT01291901
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.